Publications by authors named "Peter Zbinden"

Claim this Profile
P
Peptidomimetic antibiotics disrupt the lipopolysaccharide transport bridge of drug-resistant Enterobacteriaceae.
Matthias Schuster, Emile Brabet, Kathryn K Oi, Nicolas Desjonquères, Kerstin Moehle, Peter Zbinden

Sci Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontier Between Cyclic Peptides and Macrocycles.
Philipp Ermert, Anatol Luther, Peter Zbinden, Daniel Obrecht

Methods Mol Biol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
Anatol Luther, Matthias Urfer, Michael Zahn, Maik Müller, Shuang-Yan Wang, Peter Zbinden

Nature· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Chimeric peptidomimetic antibiotics against Gram-negative bacteria.
Anatol Luther, Matthias Urfer, Michael Zahn, Maik Müller, Shuang-Yan Wang, Peter Zbinden

Nature· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABA(A) receptor.
Christoph Joesch, Emelie Guevarra, Serge P Parel, Andreas Bergner, Peter Zbinden

J Biomol Screen· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and disposition of imatinib mesylate in healthy volunteers.
Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier, Markus Zollinger, Claudia Sayer, Peter Zbinden

Drug Metab Dispos· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput screening of beta-amyloid secretion inhibitors using homogenous time-resolved fluorescence.
Hugo Albrecht, Peter Zbinden, Andrea Rizzi, Gino Villetti, Benedetta Riccardi

Comb Chem High Throughput Screen· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of microarrayed compound screening.
Michael Hoever, Peter Zbinden

Drug Discov Today· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target proteins and mechanisms of ochratoxin toxicity. A contribution to the identification of potential ochratoxin antagonists.
Angelo Vedani, Peter Zbinden

ALTEX· January 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis